JOYCE MARTIN JOSEPH 4

4 · Aldeyra Therapeutics, Inc. · Filed Jun 9, 2022

Form 4

Period: 2022-06-07

Director

Transactions

Award
Stock Option (Right to Buy)
2022-06-07+53,812→ 53,812 total
Exercise: $3.60Exp: 2032-06-06→ Common Stock (53,812 underlying)
Award
Stock Option (Right to Buy)
2022-06-07+6,958→ 6,958 total
Exercise: $3.60Exp: 2032-06-06→ Common Stock (6,958 underlying)
Award
Stock Option (Right to Buy)
2022-06-07+1,624→ 1,624 total
Exercise: $3.60Exp: 2032-06-06→ Common Stock (1,624 underlying)

Footnotes (3)

[F1]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
[F2]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.
[F3]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date.

Documents

1 file